2-(4-chlorophenoxy)butyric acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 151501 |
| CHEMBL ID | 23477 |
| SCHEMBL ID | 3028298 |
| MeSH ID | M0151274 |
| Synonym |
|---|
| butanoic acid,2-(4-chlorophenoxy)- |
| STK501060 |
| 2-(4-chlorophenoxy)butanoic acid |
| CHEMBL23477 |
| AKOS000103672 |
| 2-(4-chlorophenoxy)butyric acid |
| BBL002691 |
| 10310-19-7 |
| butanoic acid, 2-(4-chlorophenoxy)- |
| 2-(p-chlorophenoxy)butyric acid |
| 34385-92-7 |
| AKOS016345013 |
| s-(-)cpb |
| gtpl4097 |
| AB01322784-02 |
| SCHEMBL3028298 |
| p-chlorophenoxybutyric acid |
| CEJKAKCQVUWNNA-UHFFFAOYSA-N |
| (2rs)-2-(4-chlorophenoxy)butyric acid |
| mfcd02295734 |
| CS-0206124 |
| VS-01167 |
| NCGC00327569-01 |
| DTXSID00908198 |
| EN300-228628 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " Applying extensions of a hormetic dose-response model that is well-established in plant biology provides a direct estimation of several quantities, except the hormetic dose range." | ( Statistical modeling of the hormetic dose zone and the toxic potency completes the quantitative description of hormetic dose responses. Belz, RG; Piepho, HP, 2015) | 0.42 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID191076 | Resting membrane potential in rat extensor digitorum longus(EDL) muscle fibers was determined at a concentration of 92 uM | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| AID179400 | Concentration required to block 50% chloride conductance in rat extensor digitorum longus(EDL) muscle fibers | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| AID190469 | Minimal current intensity for a long pulse for a single action potential in rat extensor digitorum longus(EDL) muscle fibers was determined at a concentration of 92 uM | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| AID188922 | Maximum number of spikes elicited by strong depolarizing pulses in rat extensor digitorum longus muscle fibers was determined at a concentration of 92 uM | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| AID179015 | Number of fibres over number of preparation sampled was determined at a concentration of 92 uM | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| AID185153 | Latency in rat extensor digitorum longus(EDL) muscle fibers was determined at a concentration of 92 uM | 1987 | Journal of medicinal chemistry, Aug, Volume: 30, Issue:8 | Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.63) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||